{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:16:20Z","timestamp":1771028180548,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.brainres.2006.09.052","type":"journal-article","created":{"date-parts":[[2006,11,14]],"date-time":"2006-11-14T12:18:59Z","timestamp":1163506739000},"page":"19-27","source":"Crossref","is-referenced-by-count":24,"title":["Anticonvulsant and anxiolytic activity of FrPbAII, a novel GABA uptake inhibitor isolated from the venom of the social spider Parawixia bistriata (Araneidae: Araneae)"],"prefix":"10.1016","volume":"1124","author":[{"given":"Jos\u00e9 Luiz","family":"Liberato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra Olimpio Siqueira","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia Renata","family":"Mortari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9rica Aparecia","family":"Gelfuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"de Oliveira Beleboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Coutinho-Netto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner Ferreira","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2006.09.052_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/1389557013406738","article-title":"Recent advances in the medicinal chemistry of polyamine toxins","volume":"1","author":"Andersen","year":"2001","journal-title":"Mini Rev. Med. Chem."},{"issue":"16","key":"10.1016\/j.brainres.2006.09.052_bib2","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1523\/JNEUROSCI.18-16-06103.1998","article-title":"Protein kinase C regulates the interaction between a GABA transporter and syntaxin 1A","volume":"18","author":"Beckman","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2006.09.052_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.03.049","article-title":"Spider and wasp neurotoxins: pharmacological and biochemical aspects","volume":"17","author":"Beleboni","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.brainres.2006.09.052_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10571-004-6913-z","article-title":"Pharmacological and biochemical aspects of GABAergic neurotransmission: Pathological and neuropsycobiological relationships","volume":"24","author":"Beleboni","year":"2004","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2006.09.052_bib5","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1124\/mol.105.017319","article-title":"Neurochemical characterization of a neuroprotective compound from Parawixia bistriata spider venom that inhibits synaptosomal uptake of GABA and Glycine","volume":"69","author":"Beleboni","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2006.09.052_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0091-3057(87)90006-2","article-title":"Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light\/dark choice situation","volume":"28","author":"Belzung","year":"1987","journal-title":"Pharmarcol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2006.09.052_bib7","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2174\/0929867013372319","article-title":"The inhibitory neural circuitry as target of antiepileptic drugs","volume":"8","author":"B\u00f6hme","year":"2001","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.brainres.2006.09.052_bib49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1021\/js980302n","article-title":"Synthesis, stability, and pharmacological evaluation of nipecotic acid prodrugs","volume":"88","author":"Bonina","year":"1999","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.brainres.2006.09.052_bib8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1076\/phbi.40.6.472.8436","article-title":"Anticonvulsant and GABA uptake inhibition properties of P. bistriata and S. raptoria spider venom fractions","volume":"40","author":"Cairr\u00e3o","year":"2002","journal-title":"Pharm. Biol."},{"issue":"3\u20134","key":"10.1016\/j.brainres.2006.09.052_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-2999(83)90497-1","article-title":"Anticonvulsant activity of GABA uptake inhibitors and their prodrugs following central or systemic administration","volume":"89","author":"Croucher","year":"1983","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.brainres.2006.09.052_bib10","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0028-3908(00)00075-7","article-title":"GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors","volume":"39","author":"Dalby","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2006.09.052_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2003.08.063","article-title":"Inhibition of y-aminobutyric acid uptake: anatomy, physiology and effects against epileptic seizures","volume":"479","author":"Dalby","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2006.09.052_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-1211(97)00033-8","article-title":"Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1","volume":"28","author":"Dalby","year":"1997","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.brainres.2006.09.052_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0169-328X(95)00101-W","article-title":"Localization of messenger RNAs encoding three GABA transporters in rat brain: an in situ hybridization study","volume":"33","author":"Durkin","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"2","key":"10.1016\/j.brainres.2006.09.052_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/exnr.1994.1060","article-title":"Blockade of GABA uptake with tiagabine inhibits audiogenic seizures and reduces neuronal firing in the inferior colliculus of the genetically epilepsy-prone rat","volume":"126","author":"Faingold","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2006.09.052_bib15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/sj.bjp.0705352","article-title":"Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake","volume":"139","author":"Fontana","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2006.09.052_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jnr.1040","article-title":"Glial transporters for glutamate, glycine and GABA: II. GABA transporters","volume":"63","author":"Gadea","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2006.09.052_bib17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1528-1157.1989.tb05825.x","article-title":"GABA in epilepsy: the pharmacologic basis","volume":"Suppl. 3","author":"Gale","year":"1989","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.brainres.2006.09.052_bib46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0387-7604(99)00113-8","article-title":"When antiepileptic drugs aggravate epilepsy","volume":"22","author":"Genton","year":"2000","journal-title":"Brain Dev."},{"key":"10.1016\/j.brainres.2006.09.052_bib18","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0028-3908(99)00233-6","article-title":"GABA potentiation: a logical approach for the treatment of acute stroke","volume":"39","author":"Green","year":"2000","journal-title":"Neuropharmacology"},{"issue":"1\u20133","key":"10.1016\/j.brainres.2006.09.052_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0014-2999(95)00835-7","article-title":"Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus","volume":"299","author":"Halonen","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2006.09.052_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0169-328X(94)90072-8","article-title":"Production of specific antibodies against GABA transporter subtypes (GAT1, GAT2, GAT3) and their application to immunocytochemistry","volume":"26","author":"Ikegaki","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"8","key":"10.1016\/j.brainres.2006.09.052_bib47","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.bcp.2004.06.039","article-title":"GABA pharmacology: what prospects for the future?","volume":"68","author":"Iversen","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"5375","key":"10.1016\/j.brainres.2006.09.052_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.281.5375.419","article-title":"Corelease of two fast neurotransmitters at a central synapse","volume":"281","author":"Jonas","year":"1998","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.brainres.2006.09.052_bib23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1471-4159.1975.tb04410.x","article-title":"Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds","volume":"25","author":"Krogsgaard-Larsen","year":"1975","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.brainres.2006.09.052_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0920-1211(87)90012-X","article-title":"GABA uptake inhibitors: relevance to antiepileptic drug research","volume":"1","author":"Krogsgaard-Larsen","year":"1987","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.brainres.2006.09.052_bib24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2006.09.052_bib25","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0021-9258(18)53968-5","article-title":"Molecular characterization of four pharmacologically distinct gamma-aminobutyric acid transporters in mouse brain [corrected]","volume":"268","author":"Liu","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.brainres.2006.09.052_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4886(89)90118-0","article-title":"Seizures evoked from Area tempestas are subject to control by GABA and glutamate receptors in substantia nigra","volume":"105","author":"Maggio","year":"1989","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2006.09.052_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(91)90567-F","article-title":"Lack of proconvulsant action of GABA depletion in substantia nigra in several seizure models","volume":"547","author":"Maggio","year":"1991","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.brainres.2006.09.052_bib50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0197-4580(00)00232-3","article-title":"The GABA uptake inhibitor tiagabine promotes slow wave sleep in normal elderly subjects","volume":"22","author":"Mathias","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2006.09.052_bib28","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1152\/jn.1989.62.5.1018","article-title":"GABA as an inhibitory neurotransmitter in human cerebral cortex","volume":"62","author":"McCormick","year":"1989","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.brainres.2006.09.052_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.toxicon.2004.02.003","article-title":"Targeting ionotropic receptors with polyamine-containing toxins","volume":"43","author":"Mellor","year":"2004","journal-title":"Toxicon"},{"issue":"11","key":"10.1016\/j.brainres.2006.09.052_bib30","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.1523\/JNEUROSCI.15-11-07734.1995","article-title":"GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex","volume":"15","author":"Minelli","year":"1995","journal-title":"J. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.brainres.2006.09.052_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neulet.2004.08.064","article-title":"A anticonvulsive fraction from Scaptocosa raptoria (Araneae: Lycosidae) spider venom","volume":"371","author":"Mussi-Ribeiro","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"5375","key":"10.1016\/j.brainres.2006.09.052_bib32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1126\/science.281.5375.360","article-title":"A tale of two transmitters","volume":"281","author":"Nicoll","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.brainres.2006.09.052_bib51","article-title":"The National Society of Epilepsy.","year":"2003","journal-title":"U.K."},{"key":"10.1016\/j.brainres.2006.09.052_bib33","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.brainres.2006.09.052_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/978-1-4757-6376-8_6","article-title":"Role of the GABA transporter in epilepsy","volume":"548","author":"Richerson","year":"2004","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.brainres.2006.09.052_bib35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.toxicon.2004.01.009","article-title":"The biological activity in mammals and insects of the nucleosidic fraction from the spider Parawixia bistriata","volume":"43","author":"Rodrigues","year":"2004","journal-title":"Toxicon"},{"issue":"10","key":"10.1016\/j.brainres.2006.09.052_bib36","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4088\/JCP.v64n1016","article-title":"Tiagabine for treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control","volume":"64","author":"Rosenthal","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.brainres.2006.09.052_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00008877-199903000-00002","article-title":"Effects of GABA-transporter (GAT) inhibitors on rat behavior in open-field and elevated plus-maze","volume":"10","author":"Schmitt","year":"1999","journal-title":"Behav. Pharmacol."},{"issue":"5\u20136","key":"10.1016\/j.brainres.2006.09.052_bib38","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s007020200071","article-title":"Anxiolytic-like effects of acute and chronic GABA transporter inhibition in rats","volume":"109","author":"Schmitt","year":"2002","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2006.09.052_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(08)60289-5","article-title":"Transport and metabolism of glutamate and GABA in neurons are glial cells","volume":"22","author":"Schousboe","year":"1981","journal-title":"Int. Rev. Neurobiol."},{"issue":"3","key":"10.1016\/j.brainres.2006.09.052_bib52","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1471-4159.1986.tb00676.x","article-title":"Tissue distribution, metabolism, anticonvulsant efficacy and effect on brain amino acid levels of the glia-selective gamma-aminobutyric acid transport inhibitor 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridin-3-ol in mice and chicks","volume":"47","author":"Schousboe","year":"1986","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.brainres.2006.09.052_bib40","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.bcp.2004.06.041","article-title":"GABA transporters as drug targets for modulation of GABAergic activity","volume":"68","author":"Schousboe","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.brainres.2006.09.052_bib53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00004714-200106000-00020","article-title":"Tiagabine, a specific gamma-aminobutyric acid transporter-1 inhibitor, in the treatment of psychosis","volume":"21","author":"Sharma","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.brainres.2006.09.052_bib41","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1528-1157.1995.tb02576.x","article-title":"A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor","volume":"36","author":"Suzdak","year":"1995","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.brainres.2006.09.052_bib42","first-page":"315","article-title":"Distribution of mRNA for the GABA transporter GAT-1 in the rat brain: evidence that GABA uptake is not limited to presynaptic neurons","volume":"185","author":"Swan","year":"1994","journal-title":"J. Anat."},{"issue":"13","key":"10.1016\/j.brainres.2006.09.052_bib43","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1523\/JNEUROSCI.20-13-04904.2000","article-title":"Immunoisolation of GABA-specific synaptic vesicles defines a functionally distinct subset of synaptic vesicles","volume":"20","author":"Takamori","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2006.09.052_bib44","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0028-3908(01)00026-0","article-title":"Preclinical avaliation of CHF3381 as a novel antiepileptic agent","volume":"40","author":"Villetti","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2006.09.052_bib45","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1124\/jpet.102.034819","article-title":"Correlation between anticonvulsant activity and inhibitory action on glial Gaba uptake of the highly selective mouse Gat1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-12-benzisoxazole (Exo-Thpo) and its N-alkylated analogs","volume":"302","author":"White","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899306027946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899306027946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T18:23:33Z","timestamp":1628101413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899306027946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0006899306027946"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2006.09.052","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}